D&DIAGNOSIS & EARLY DETECTION
Diagnosis & Early Detection/November 9, 2026/3 min read

Three Connected Technologies Are Changing How Teens Manage Type 1 Diabetes

Continuous glucose monitors, automated insulin delivery systems, and remote care are working together to help adolescents achieve better blood sugar control and reduce serious complications. Here's what the latest research shows.

Research summaryPubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

  • Hybrid closed-loop insulin devices consistently improve time in range and lower HbA1c levels, while also reducing severe low blood sugar events and diabetic ketoacidosis
  • Remote care models—where doctors monitor data between visits—produce similar glycemic outcomes to in-person appointments while improving access and emotional support
  • Real-time glucose data works best when paired with structured education to help teens understand patterns and make informed decisions
  • Access gaps remain: socioeconomic inequities, alarm fatigue, and uneven healthcare system adoption mean not all teens benefit equally from these advances

How These Three Technologies Work Together

Managing Type 1 diabetes in the teen years is complex. Adolescents face unique physiological challenges—like growth spurts and hormonal changes—alongside behavioral factors that make steady blood sugar control difficult. Three interconnected tools are reshaping how this works: continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, and remote care.

CGMs measure glucose levels in real time, giving teens and their families a constant stream of data. The key measure doctors track is time in range (TIR)—the percentage of time blood sugar stays in the target zone. When paired with education and support, CGMs help teens see patterns they might otherwise miss.

What Research Shows About Automated Insulin Delivery

Hybrid closed-loop devices represent a major step forward. These systems combine a glucose sensor, insulin pump, and algorithm that automatically adjusts insulin doses based on real-time readings. Randomized trials and real-world studies consistently show that hybrid closed-loop systems increase time in range, lower HbA1c levels, and reduce the risk of both severe hypoglycemia (dangerously low blood sugar) and diabetic ketoacidosis (DKA), a serious complication.

These benefits have been validated across a wide age range—even in children as young as 1 year old. The consistency of these results across different study types and populations underscores how effectively the technology performs when properly implemented.

Remote Care: Bringing Doctor Visits Into the Digital Age

Remote care models leverage the continuous data streams from CGMs to enable more personalized follow-up between—and sometimes instead of—in-person visits. Rather than waiting three months for the next appointment, doctors can monitor trends and adjust care plans using real-time information.

Comparative studies show that remote care produces glycemic outcomes approaching those of traditional office visits, while improving access to care and strengthening psychosocial support. For teens with transportation barriers, busy schedules, or limited access to endocrinology specialists, this shift can be transformative.

The Remaining Gaps and Future Directions

Despite the proven benefits, significant barriers remain. Access to these technologies depends heavily on insurance coverage and economic resources, creating inequities in who can use them. Additionally, constant alerts from glucose monitors can lead to alarm fatigue, where teens and families become overwhelmed by notifications. Healthcare systems themselves vary widely in how well they've integrated these tools into clinical practice.

Looking ahead, researchers and clinicians are working toward fully automated closed-loop systems, dual-hormone approaches (combining insulin with glucagon), and algorithms refined specifically for exercise and illness. Equally important are studies on long-term psychosocial outcomes and strategies to ensure equitable access across all communities. The goal is to shift adolescent diabetes care from isolated office visits to true continuous digital management, supported by multidisciplinary teams and centered on what each teen and family actually needs.

Evidence label

Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Read more of our own writing in Stories

More evidence-labeled coverage across the Type1Cure library.